On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
MondayApr 10, 2023 9:45 am

D-Wave Quantum Inc. (NYSE: QBTS) Provides Practical Quantum Computing Solutions to Help Companies Improve Operational Efficiencies and Navigate Complexity

D-Wave has worked on quantum hybrid applications with commercial customers including industry leaders like Volkswagen, Mastercard, Deloitte, ArcelorMittal, Siemens Healthineers, Unisys, Accenture, BBVA, NEC Corporation, Pattison Food Group Ltd., DENSO, and Lockheed Martin The company’s intellectual property portfolio includes more than 210 issued US patents and more than 100 peer-reviewed papers in leading scientific journals D-Wave’s customer success stories showcase the company’s quantum computing technology in action D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services, focused on delivering value to customers via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug…

Continue Reading

MondayApr 10, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Revolutionizing Drug Delivery Potential for Active Pharmaceutical Ingredients Using Patented DehydraTECH(TM) Technology

DehydraTECH(TM)-enabled drugs and product formats improve the speed of onset, increase bioavailability, increase brain absorption, enhance drug potency, reduce drug administration costs, and mask unwanted tastes, shown effective with a growing number of medical applications Current DehydraTECH studies (animal and human) include hypertension, dementia, oral nicotine, epilepsy, and diabetes Most recently, Lexaria’s DehydraTECH-CBD studies for hypertension have produced positive results, and the company is seeking IND status with the FDA Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has developed a disruptive drug delivery technology with multiple opportunities for success in cannabinoids, oral nicotine and other active…

Continue Reading

ThursdayApr 06, 2023 9:45 am

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Releases Promising Update on Iska Iska Project at Metals Investor Forum

Eloro Resources released updates on Iska Iska project at Metals Investor Forum held in Toronto on March 3-4, 2023 Iska Iska is a major silver-tin polymetallic porphyry-epithermal complex located in southern Bolivia Drilling revealed significant breccia pipe containing extensive silver polymetallic mineralization and a high-grade gold-bismuth zone in the underground workings Eloro recently acquired Mina Casiterita and Mina Hoyada properties, geological mapping, sampling, and geophysical surveys in progress, drilling planned in Q1-2023 Dr. Bill Pearson, Executive Vice President of Exploration for Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) recently revealed promising drilling results from the company’s Iska Iska project…

Continue Reading

ThursdayApr 06, 2023 9:00 am

McEwen Mining Inc.’s (NYSE: MUX) (TSX: MUX) McEwen Copper Advancing Los Azules Project amid Copper Supply Bottlenecks and Growing Demand

McEwen Mining is an asset-rich diversified gold and silver producer in the Americas with significant exposure to copper through its 51.9%-owned McEwen Copper McEwen Copper holds 100% interest in the Los Azules Project in Argentina, which has been shown to have many attributes comparable to world-class copper-gold deposits in South America The subsidiary is advancing the Los Azules Project and has been undertaking infill and step-out exploration drilling McEwen Copper’s focus comes at a time when the world is staring at copper deficits driven by constrained supply amid political instability in top copper-producing countries and increased demand Copper, a base…

Continue Reading

WednesdayApr 05, 2023 10:30 am

DGE’s 2nd Diversity in Clinical Trials Summit: Revolutionizing Trial Outcomes through Improved Diversity Outreach and Representation

Chief Medical Officers, Clinical Research Executives, and Patient Advocacy Experts: attend DGE's 2nd Diversity in Clinical Trials Summit, taking place May 10-11 in Philadelphia, PA. Join this unique in-person learning and networking experience aimed to remove obstacles in health equity and provide actionable strategies to increase diverse representation in clinical trials. DGE is bringing together industry-leading experts from global clinical development to discuss the most critical challenges barriers, and methods on how to overcome barriers in order to reduce disparities and achieve health equity. The agenda focuses on increasing representation of underrepresented communities in clinical trials, improving collaborations with patient…

Continue Reading

WednesdayApr 05, 2023 9:45 am

Sustain SoCal presents The Future of Housing in CA: Building Sustainable Communities

Housing industry and government leaders, specialist delegates, and property experts, are all invited to attend the Future of Housing event taking place on April 25, 2023. Hosted by Sustain SoCal at UCI-Beal Applied Innovation, Irvine, this insightful event will bring the housing community together to nurture best practices and explore ideas. The Future of Housing event is an assorted continuum of housing stakeholders that collaborate and convene through advocacy, dialogue, education, and research, to develop equitable solutions that serve our common interest. The Future of Housing event strives to deliver solutions that address California’s pressing housing priorities. Attendees can take…

Continue Reading

WednesdayApr 05, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting Multiple Commercial Applications for Its Patented DehydraTECH(TM) Technology Platform

Lexaria Bioscience, a global innovator in drug delivery platforms, has developed and patented the DehydraTECH(TM) drug delivery platform technology The company has undertaken multiple studies as part of its extensive R&D program involving DehydraTECH, which continues to yield positive results This R&D program is focused on the development of product candidates across four main segments, which represent the platform’s potential commercial applications These segments include the development of DehydraTECH-processed cannabidiol (“CBD”) for hypertension, epilepsy, diabetes and dementia; DehydraTECH-processed oral nicotine; other pharmaceutical areas exploring a wide range of DehydraTECH-processed active molecules; and hemp-derived CBD applications for consumer packaged goods (“CPG”)…

Continue Reading

TuesdayApr 04, 2023 11:15 am

Green Housing Market Coast-to-Coast Creates Opportunity for GeoSolar Technologies Inc.

Assurance released a new study ranking every state for 11 sustainability factors ranging from solar power to electric heat and recycling regulations, with Oregon coming out on top GeoSolar Technologies is an emerging leader in the space with its new Smart Green(TM) Home that includes a rooftop solar system, geothermal loops, EV charging station, and more As measured by the HERS Index, a Smart Green(TM) Home is essentially 100% more efficient than a typical home built in 2006 Whether motivated by financial incentives, environmental concerns, or both, people are increasingly looking to climate and wallet friendly technologies in their homes.…

Continue Reading

TuesdayApr 04, 2023 10:30 am

Cepton, Inc. (NASDAQ: CPTN) Announces 2022 Financial Results With 65% YoY Growth in Revenues

Cepton, Inc. recently published its 4Q22 and FY22 financial results The company revealed that it had generated FY22 revenues of $7.4 million, up by 65% relative to FY21 results. Furthermore, Cepton guided for FY23 revenues of $15-20 million Cepton is at the forefront of lidar technology development, a position they’ve further consolidated with the recent launch of their award-winning Vista® X-120 Plus sensors Cepton (NASDAQ: CPTN), a Silicon Valley innovator and pioneer within high-performance MMT® lidar solutions, recently announced their financial results for the fourth quarter and full year ending December 31, 2022 (https://ibn.fm/6wp95). The company reported full year 2022…

Continue Reading

TuesdayApr 04, 2023 9:45 am

Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Is ‘One to Watch’

The FEXD management team has extensive international experience in developing global fintech platforms and services The company in September 2022 announced a business combination with Rana Financial, which provides transfer of funds services between the U.S. and Latin America At that same time, FEXD announced the acquisition of Afinoz, a digital lending platform used by India’s leading banks In January 2023 the company announced an extension to close its announced business combinations with Rana and Afinoz through April 2023 Fintech Ecosystem Development (NASDAQ: FEXD) is a special purpose acquisition company (“SPAC”) formed for the purpose of effecting one or more…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered